Published: 2/25/2026 12:08:04 PM
This is a news from the Finwire news agency Disclaimer
The research company Dextech reports, as planned, no revenue in the second quarter. The operating loss increased."The company has previously communicated that existing financing secures operations through the end of 2026. Following updated cost forecasts and current liquidity, the board assesses that working capital is sufficient to finance the current operations at least through the end of 2028," says vd Anders R Holmberg. The operating result was -1.7 million kronor (-1.1). The result before tax was -1.6 million kronor (-1.0). The result after tax was -1.6 million kronor (-1.0). Earnings per share amounted to -0.09 kronor (-0.05). Cash and cash equivalents amounted to 12.2 million kronor (16.3).Dextech, MkrQ2-2025/2026Q2-2024/2025ChangeNet sales00Operating result-1.7-1.1Result before tax-1.6-1.0Net income-1.6-1.0Earnings per share, kronor-0.09-0.05Cash and cash equivalents12.216.3-25.2%
Read more about DexTech Medical AB